期刊文献+

雌激素受体基因ERβ与小鼠成骨细胞的增殖和分化 被引量:6

Estrogen receptor beta inhibits the proliferation and differentiation of osteoblasts in mice
下载PDF
导出
摘要 背景:雌激素受体ERs表达于所有关系到骨形成和骨吸收的细胞成分中。目的:观察雌激素受体ERβ对成骨细胞增殖、分化能力的调控作用。方法:以小鼠成骨细胞株MC3T3-E1为对象,设立3组:实验组转染雌激素受体ERβ RNAi载体、阴性对照组转染ERL RNAi载体、空白对照组不进行转染,3组在相同条件下培养。采用MTT法绘制各组细胞的生长曲线;流式细胞仪分析各组细胞的细胞周期。结果与结论:实验组成骨细胞的增殖能力明显高于空白对照组和阴性对照组,G1期细胞百分率明显少于空白对照组和阴性对照组,而S期和G2期细胞百分率明显高于空白对照组和阴性对照组(P均<0.05)。根据雌激素受体ERβ沉默后检测的结果可以反向推断,ERβ的表达对成骨细胞的增殖、分化具有抑制作用。 BACKGROUND:Estrogen receptors (ERs) are expressed in cell components related to bone formation and resorption. OBJECTIVE:To investigate the regulatory effects of Erβ on osteoblast proliferation and differentiation. METHODS:The mouse osteoblastic cell lines MC3T3-E1 were divided into 3 groups:experimental group (transfected ERβRNAi vector), negative control (transfected ERL RNAi vector), and blank control (no transfection). Three groups of cells were cultured under the same conditions. In each group, cell growth curve was drawn using MTT; and the cell cycle was analyzed by flow cytometry. RESULTS AND CONCLUSION:The cell proliferation in the experimental group was more significantly enhanced than in the negative control group or blank control group. The percentage of cells at G1-phase in the experimental group was significantly less than the other groups, while the percentage of cells at S-phase and G2-phase was significantly higher than the other groups (P 0.05). According to test results of the ERβ silence, we can infer that the ERβ may inhibit the proliferation and differentiation of osteoblasts.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第28期5157-5160,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 湖南省研究生科研创新项目资助(CX2010B101)~~
  • 相关文献

参考文献14

  • 1张玥,王立军,任甫,席焕久,范英南.核心结合因子α_1、雌激素受体α基因多态性与骨发育的相关性[J].中国组织工程研究与临床康复,2009,13(46):9159-9162. 被引量:2
  • 2汤富磊,冯娟.小鼠基因修饰基本原理及其在医学研究中的应用--2007年诺贝尔生理学或医学奖及其相关工作介绍[J].生理科学进展,2008,39(3):282-288. 被引量:2
  • 3Lanyon L,Armstrong V,Ong D,et al.Is estrogen receptorαkey to controlling bones’’resistance to fracture?. The Journal of Endocrinology . 2004
  • 4Richardson TI,Dodge JA,Durst GL,et al.Benzopyrans as selective estrogen receptor beta agonists (SERBAs).Part3:synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification. Bioorganic and Medicinal Chemistry . 2007
  • 5Wiren KM,Chapman EA,Zhang XW.Osteoblast differentiation influences androgen and estrogen receptor alpha and beta expression. The Journal of Endocrinology . 2002
  • 6Bhargavan B,Singh D,Gautam AK,et al.Medicarpin,a legume phytoalexin,stimulates osteoblast differentiation and promotes peak bone mass achievement in rats:evidence for estrogen receptorβ-mediated osteogenic action of medicarpin. Journal of Nutritional Biochemistry . 2011
  • 7Revankar C M,Cimino D F,Sklar L A,et al.A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science . 2005
  • 8WINDAHL SH,NORGARD M,KUIPER G,et al.Cellular dis-tribution of estrogen receptorβin neonatal rat bone. Bone . 2000
  • 9Nelson D M,Ye X,Hall C,et al.Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/ cdk2 activity. Molecular and Cellular Biology . 2002
  • 10Fabio Stossi,Daniel H. Barnett,Jorma Frasor, et al.Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER)α or ERβ in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors. Endocrinology . 2004

二级参考文献62

  • 1李文琪,范少光.嗅觉研究进展——2004年诺贝尔生理学或医学奖获奖工作简介[J].生理科学进展,2006,37(1):83-96. 被引量:7
  • 2付华斌,杨清武,安建宏,杨程,王琳.重庆地区正常汉族人群雌激素受体基因多态性的分布特征[J].四川医学,2007,28(3):267-269. 被引量:2
  • 3Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89(5):765-771.
  • 4Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89(5):755-764.
  • 5Ducy P, Starbuck M, Priemel M, et al. A Cbfal-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999;13(8):1025-1036.
  • 6Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997; 89(5):773-779.
  • 7Thirunavukkarasu K, Mahajan M, Mclarren KW, et al. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol cell biol. 1998; 18(7): 4197-4208.
  • 8Vaughan T, Pasco JA, Kotowicz MA, et al. Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture.J Bone Miner Res. 2002; 17(8) 1527-1534.
  • 9Bustamante M, Nogu6s X, Agueda L, et al. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women. Calcif Tissue Int. 2007; 81 (4):327-332.
  • 10Shin HD, Jeon J, Park BL, et al. Novet promoter potymorphism in RUNX2 is associated with serum triglyceride level. Molecules and cells. 2008; 11 (26): 459-461.

共引文献2

同被引文献126

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部